{"id":140124,"date":"2024-02-11T22:44:52","date_gmt":"2024-02-11T22:44:52","guid":{"rendered":"https:\/\/dailytalks.org\/?p=140124"},"modified":"2024-02-11T22:44:52","modified_gmt":"2024-02-11T22:44:52","slug":"tisa-cel-yields-durable-responses-in-r-r-follicular-lymphoma","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=140124","title":{"rendered":"Tisa-Cel Yields Durable Responses in R\/R Follicular Lymphoma"},"content":{"rendered":"<p>MedPage Today) &#8212; Patients with relapsed\/refractory follicular lymphoma experience durable responses when treated with tisagenlecleucel (tisa-cel, Kymriah) according to new 3-year data from the phase II ELARA study presented at the recent American&#8230;<br \/><a href=\"https:\/\/www.medpagetoday.com\/meetingcoverage\/ashexpertroundtablefollicularlymphoma\/107997\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MedPage Today) &#8212; Patients with relapsed\/refractory follicular lymphoma experience durable responses when treated with tisagenlecleucel<\/p>\n","protected":false},"author":1,"featured_media":140125,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[41],"tags":[],"class_list":["post-140124","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-americas"],"featured_image_urls":{"full":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/02\/140124-tisa-cel-yields-durable-responses-in-r-r-follicular-lymphoma.jpg",1600,900,false],"thumbnail":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/02\/140124-tisa-cel-yields-durable-responses-in-r-r-follicular-lymphoma-150x150.jpg",150,150,true],"medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/02\/140124-tisa-cel-yields-durable-responses-in-r-r-follicular-lymphoma-300x169.jpg",300,169,true],"medium_large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/02\/140124-tisa-cel-yields-durable-responses-in-r-r-follicular-lymphoma-768x432.jpg",640,360,true],"large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/02\/140124-tisa-cel-yields-durable-responses-in-r-r-follicular-lymphoma-1024x576.jpg",640,360,true],"1536x1536":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/02\/140124-tisa-cel-yields-durable-responses-in-r-r-follicular-lymphoma-1536x864.jpg",1536,864,true],"2048x2048":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/02\/140124-tisa-cel-yields-durable-responses-in-r-r-follicular-lymphoma.jpg",1600,900,false],"chromenews-featured":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/02\/140124-tisa-cel-yields-durable-responses-in-r-r-follicular-lymphoma-1024x576.jpg",1024,576,true],"chromenews-large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/02\/140124-tisa-cel-yields-durable-responses-in-r-r-follicular-lymphoma-825x575.jpg",825,575,true],"chromenews-medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/02\/140124-tisa-cel-yields-durable-responses-in-r-r-follicular-lymphoma-590x410.jpg",590,410,true]},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=41\" rel=\"category\">Americas<\/a>","tag_info":"Americas","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/140124","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=140124"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/140124\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/media\/140125"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=140124"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=140124"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=140124"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}